Use of random-sequence riboflavin as a marker of medication compliance in chronic schizophrenics
- 31 December 1991
- journal article
- clinical trial
- Published by Elsevier in Schizophrenia Research
- Vol. 6 (1) , 49-53
- https://doi.org/10.1016/0920-9964(91)90020-r
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Adherence to Lithium Prophylaxis: I. Clinical Predictors and Patient's Reasons for NonadherencePharmacopsychiatry, 1988
- Clinical symptomatology and drug compliance in schizophrenic patientsActa Psychiatrica Scandinavica, 1988
- Amitriptyline metabolism in relation to antidepressive effectClinical Pharmacology & Therapeutics, 1984
- Medication noncompliance: Systematic approaches to evaluation and interventionGeneral Hospital Psychiatry, 1983
- A behavioral medicine perspective on adherence to long-term medical regimens.Journal of Consulting and Clinical Psychology, 1982
- An evaluation of the potential use of isoniazid, acetylisoniazid and isonicotinic acid for monitoring the self-administration of drugs.Published by Wiley ,1980
- CommentaryClinical Pharmacology & Therapeutics, 1977
- Treatment AdherenceThe British Journal of Psychiatry, 1976
- Why Do Schizophrenic Patients Refuse to Take Their Drugs?Archives of General Psychiatry, 1974
- Measuring intake of a prescribed medication A bottle count and a tracer technique comparedClinical Pharmacology & Therapeutics, 1970